Appendix D
1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes


1. Develop new and improved vaccines

2. Ensure the optimal safety and effectiveness of vaccines and immunizations

3. Better educate the public and members of the health professions on the benefits and risks of immunizations

4. Achieve better use of existing vaccines to prevent disease, disability, and death


1.1 Develop new and improved vaccines for priority diseases

2.1 Enhance the ability to evaluate the safety and effectiveness of vaccines

3.1 Increase public demand for immunization, especially among populations at risk of underimmunization

4.1 Ensure an adequate supply of vaccines

1.2 Ensure the Nation’s capability to detect and respond effectively to new and emerging diseases in the United States and abroad

2.2 Improve the surveillance and evaluation of adverse events following vaccination

3.2 Improve the immunization practices of all health care providers

4.2 Increase immunization coverage levels for infants and children

1.3 Enhance the process of translating technologic innovations into new vaccines

2.3 Ensure the optimal use of vaccines

3.3. Increase the awareness of the benefits of immunization among special target audiences (third-party payers, employers, legislators, community leaders, hospital administrators, etc.)

4.3 Maintain immunization coverage levels for school-aged children

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 26
Appendix D 1994 National Vaccine Plan Goals, Objectives, and Anticipated Outcomes GOALS 1. Develop new and 2. Ensure the optimal 3. Better educate the 4. Achieve better use of improved vaccines safety and effectiveness of public and members of the existing vaccines to vaccines and health professions on the prevent disease, disability, immunizations benefits and risks of and death immunizations OBJECTIVES 1.1 Develop new and 2.1 Enhance the ability to 3.1 Increase public 4.1 Ensure an adequate improved vaccines for evaluate the safety and demand for immunization, supply of vaccines priority diseases effectiveness of vaccines especially among populations at risk of underimmunization 1.2 Ensure the Nation’s 2.2 Improve the 3.2 Improve the 4.2 Increase immunization capability to detect and surveillance and evaluation immunization practices of coverage levels for infants respond effectively to new of adverse events all health care providers and children and emerging diseases in following vaccination the United States and abroad 1.3 Enhance the process 2.3 Ensure the optimal use 3.3. Increase the 4.3 Maintain of translating technologic of vaccines awareness of the benefits immunization coverage innovations into new of immunization among levels for school-aged vaccines special target audiences children (third-party payers, employers, legislators, community leaders, hospital administrators, etc.) 26

OCR for page 26
APPENDIX D 27 1.4 Ensure the Nation’s 2.4 Continue to ensure 3.4 Develop more 4.4 Increase immunization capability to evaluate new fair and efficient effective methods of coverage levels among vaccines, and to conduct compensation to communicating the older adolescents, adults, prompt reviews of new individuals injured by benefits and risks of and the elderly and improved candidate vaccines immunization to health vaccines care providers, patients, and parents/guardians 1.5 Promote the 2.5 Promote and support 3.5 Continue to evaluate 4.5 Improve the improvement of existing the efforts of the World the benefits and impact of surveillance of vaccine vaccines and development Health Organization to immunization through the preventable diseases to of new vaccines ad develop and harmonize use of cost-effectiveness assess the impact of vaccine-related international standards and studies immunization programs technologies for other improve regulatory diseases of importance in capabilities in countries developing countries involved in vaccine production 4.6 Establish registry and immunization tracking systems 4.7 Enhance immunization coverage to strengthen national defense 4.8 Enhance immunization coverage of international travelers who are of highest risk of acquiring vaccine- preventable diseases 4.9 Eradicate poliomyelitis globally 4.10 Promote better control of neonatal tetanus and measles, worldwide 4.11 Promote the self- sustaining capacity of immunization programs in developing countries ANTICIPATED15 OUTCOMES Provision of adequate resources to make possible the vigorous and comprehensive pursuit of the wide range of activities outlined in the National Vaccine Plan could result in substantial health benefits for the American people by the year 2000. These benefits are expected to be realized as the following outcomes: 15 Also described as “predicted” outcomes in the National Vaccine Plan

OCR for page 26
28 INITIAL GUIDANCE Age-appropriate immunization with all recommended vaccines will be • extended to at least 90 percent of infants and children, and access to affordable vaccination services will be made available for every person in the United States. Diphtheria, tetanus, poliomyelitis, measles, rubella, mumps, some forms of • hepatitis, pertussis (whooping cough), and bacterial meningitis (from Haemophilus influenzae type b) will be essentially eliminated as significant causes of death, disease, and disability in the United States. Educational communication networks will be in place that will inform all • health care providers, communities, and families of the benefits and risks of vaccination. In a global context, polio will be drastically reduced, if not eliminated, and • neonatal tetanus and measles will be better controlled. Pneumococcal pneumonia and influenza in American adults over the age of • 65 will be significantly reduced. A nationwide system will monitor the vaccines that children receive, and will • remind parents when individual infants and children should be vaccinated. A nationwide surveillance system will report and investigate cases of vaccine- • preventable diseases. Vaccine safety and efficacy will be continuously monitored, and adverse • events following immunization will be reported and carefully analyzed. Improved vaccines will replace some of the vaccines in current use. • Some vaccines requiring multiple doses and multiple contacts with the health • care system will be replaced by more cost-effective ones that will improve people’s access to immunization. Many new vaccines will be developed, or be much closer to licensure, for • diseases for which effective vaccines do not now exist. New mechanisms for the more rapid assessment of vaccines proposed for • licensure will be in place. A reliable supply of all recommended vaccines and a capability to respond to • emergencies and emergent threats to public health will be achieved and sustained. Information on the cost and benefits of the National Vaccine Plan will be • made available on an ongoing basis to the American people.